Abstract

Severe Acute respiratory syndrome coronavirus (SARS-CoV-1) attaches to the host cell surface to initiate the interaction between the receptor-binding domain (RBD) of its spike glycoprotein (S) and the human Angiotensin-converting enzyme (hACE2) receptor. SARS-CoV-1 mutates frequently because of its RNA genome, which challenges the antiviral development. Here, we per-formed computational saturation mutagenesis of the S protein of SARS-CoV-1 to identify the residues crucial for its functions. We used the structure-based energy calculations to analyze the effects of the missense mutations on the SARS-CoV-1 S stability and the binding affinity with hACE2. The sequence and structure alignment showed similarities between the S proteins of SARS-CoV-1 and SARS-CoV-2. Interestingly, we found that target mutations of S protein amino acids generate similar effects on their stabilities between SARS-CoV-1 and SARS-CoV-2. For example, G839W of SARS-CoV-1 corresponds to G857W of SARS-CoV-2, which decrease the stability of their S glycoproteins. The viral mutation analysis of the two different SARS-CoV-1 isolates showed that mutations, T487S and L472P, weakened the S-hACE2 binding of the 2003–2004 SARS-CoV-1 isolate. In addition, the mutations of L472P and F360S destabilized the 2003–2004 viral isolate. We further predicted that many mutations on N-linked glycosylation sites would increase the stability of the S glycoprotein. Our results can be of therapeutic importance in the design of antivirals or vaccines against SARS-CoV-1 and SARS-CoV-2.

Highlights

  • The severe acute respiratory syndrome coronavirus (SARS-CoV-1) belongs to a family of Coronaviridae that are enveloped, positive-strand RNA viruses (Li F. et al, 2005)

  • We indicated that SARS-CoV-2 has a stronger affinity towards human Angiotensin-converting enzyme 2 (hACE2) than SARS-CoV-1 because of its higher electric field density (Xie et al, 2020)

  • We performed the structural alignment of the receptor-binding domain (RBD) of SARS-CoV-1(PDB ID: 2AJF, chain E) and SARS-CoV-2 (PDB ID: 6M17, chain E), and it yielded an RMSD of 1.043

Read more

Summary

Introduction

The severe acute respiratory syndrome coronavirus (SARS-CoV-1) belongs to a family of Coronaviridae that are enveloped, positive-strand RNA viruses (Li F. et al, 2005). In November 2002, the first case of SARS-CoV-1 occurred in the Guangdong province in China. In 2004, there were four mild cases of SARS-CoV-1 outbreak. The recent outbreak of a newer strain of coronavirus, SARS-CoV-2, began in December 2019 in the Wuhan city in China (Vankadari and Wilce, 2020). In a month, this new coronavirus had spread across the world due to global travels. As of November 11, 2021, the number of confirmed global cases and global deaths due to SARS-CoV-2 are ∼252 million and ∼5.1 million, respectively (Dong et al, 2020)

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.